MnA round-up: BD gets into next-gen sequencing; Danaher casts off communications biz
This article was originally published in Clinica
Executive Summary
Becton Dickinson has taken a step into the next-generation genome sequencing arena, acquiring GenCell Biosystems for an undisclosed fee. The privately-held Irish biotech company, founded in 2011, has created an automated platform that could address unmet needs in library preparation from next-generation sequencing, it said.